Panacea Pharmaceuticals, Inc. to Present at BIO 2001 International Investor & Partnering Forum

ROCKVILLE, Md.--(BW HealthWire)--June 21, 2001--Panacea Pharmaceuticals, Inc. will present an update on the development of its platform technology for the treatment and diagnosis of cancer at the BIO 2001 International Investor and Partnering Forum in San Diego on Tuesday, June 26 at 5:30pm (EST).

Lawrence Glass, the Company's Senior Vice-President for Corporate Development, will give the presentation.

This event will be web cast for viewers at: http://www.InformedInvestors.com, look for Panacea Pharmaceuticals under Informed Investors presenting companies. The web cast will be archived on the company's web site at www.PanaceaPharma.com.

About Panacea Pharmaceuticals

Panacea Pharmaceuticals, Inc. is a development stage biopharmaceutical company focused on utilizing functional genomics and proteomics to develop therapeutics for cancer, Alzheimer's disease, and Parkinson's disease as well as tests for the diagnosis and management of cancer.